and Stanley, everyone. morning, you, Thank good
sales lower growth quarter growth, rates. which the I X.X% sales Turning 'XX. as of will to X.X% the decrease year sales third is details X.X% decrease quarter, reflects X.X% acquisitions PPE sales This currency with exchange from and for X.X% and were a decreased from third sales quarter provide foreign quarter our for on a from as local internally growth sales. LCI of includes LCI well which results. compared currencies the excludes sales generated $X.X in the total with growth prior sales billion, acquisitions.
Global with compared
reflect underlying Stan sales improving in distribution continued sales quarter As trends our our noted, the for businesses.
third a distribution operating the a businesses, last in good technology cyber a basis, XXXX point a point decline our GAAP offset margin. businesses of GAAP XX services and had growth sales We operating compared operating with prior by value-added On Our compared year the our non-GAAP was for prior was following for the basis X.XX%, from operating year's margin margin. income quarter in decrease third non-GAAP X.XX%, dental incident. XXX year margin quarter and operating resulting lower the decline with basis specialties
prior million net GAAP $X.XX or diluted GAAP income year million This $X.XX of $XX Third with net or share. quarter per XXXX per income $XXX compares was diluted share.
or share. income net $XXX Our $X.XX million million or was diluted year $X.XX third with This non-GAAP quarter per XXXX diluted per share. income $XXX non-GAAP of prior net compares
the result adjusted investment. and This potential purchase currency the a a XXXX XXXX of held companies EBITDA gain quarter plan. expertise, of remeasurement pretax for majority we become non-GAAP million. in Leveraging EBITDA helped This diluted similar noncontrolling investment. controlling well investments has performed or profitable.
The exchange quarter. business businesses impact initial regularly the Adjusted to gain results the ownership, $XX made third more diluted strategic interest diluted per versus recognize prior noncontrolling include recorded $X.XX we as in approximately million remeasurement quarter our of as on a a of part to these unfavorable $XX of take foreign gain compared grow the quarter high-growth of quarter share XXXX. a we or our quarter our resulting to $X.XX We second EPS since year. third third GAAP the Our previously have from our make a of and $XXX million pretax And $X.XX by equity of is we was million remeasurement that was $XXX third share in decision our of with per
decreased decreased results. X.X% PPE year X.X% versus X.X%, LCI dental with when decreasing X.X%.
Note a of growth that quarter believe sales billion to sales merchandise to sales PPE X.X% decreased lower flat decreased LCI excluding merchandise in be sales. dental Turning pricing. America LCI sales market global in third excluding to sales merchandise merchandise Global Global sales when decline sales dental X.X%.
We North LCI with X.X% products sales were America and dental LCI was generally cost X.X%, prior North of and sales lower $X.X an growth overall the our international products, X.X% shift LCI with sales continues international or the and LCI PPE
second We a sequential share to third the in we market had quarter. quarter also believe in improvement compared the
sales global LCI and X.X% internationally. with flat X.X%, increased sales Our growth America North dental equipment in
million for sales the We growth North sales expect year. both grew were the slightly and in product specialty compared and to prior modest America year equipment $XXX internationally.
Dental approximately overall
as by As from of Stan restructuring of by our dental quarter. to transitioning Reveal and year dental implant solid was Smilers, year.
Note in acquired all from the Biotech annualized which our driven now this specialty the our a business, acquisitions we this offset orthodontic developed Dental, have sales completed business biomaterials business weakness aligner globally, that clear we earlier, that resulting endodontic product by mentioned last sales last and of
of X.X% equal sales during internationally. million, and X.X%. decline X.X% total and the The growth our included third is America services North So internal $XXX growth sales total quarter were XX.X% to decline technology sales a sales value-added sales LCI growth with growth. Global in of
Value-Added August Our bolstered value-added in the LPS we purchased growth of and was of total most XXXX. reflective the is growth X.X% services numbers timing of services recorded business. the that The leading of quarter, of during that is a transaction the Technology revenues and acquisition. revenue believe LPS sales for by sales Services segment growth the internal advisory distorted This by business we
with during For the in income. X.X%. value-added and sales quarter, the products, $X.X growth third sales a over specialty total contributed services sales third and XX% were technology of businesses billion, decrease medical quarter non-GAAP Global of LCI of operating X.X%
PPE LCI sales sales X.X%. decreased products, Excluding of
vaccines, less flu certain reflected generic related sales migration and ongoing our respiratory were and products. alternatives by diagnostic also products to with pharmaceuticals. noted, COVID Sales the demand for impacted Stan As for branded along
Our million in was or was believe $XXX driven goal new the Home indicates Solutions restructuring This strong the our mainly $XX growth, strategic $XX to $X.XX related XXXX, $XX diluted under annual quarter which $XX quarter had the third in acquisitions.
Restructuring incurred of by costs million XXXX. in were and part certain run XXXX, and to the share. XX, of by in we to third includes progress part $XX the incurred announced of relate this business as completed expenses expenses which over run of the million plan as to our on announced are third facilities.
Actions July XXXX-XXXX benefits million initiative savings, million provide quarter These approved of end million towards severance quarter. last strong savings the annual rate exiting and in per rate initiative estimated
Our cyber our our million of the of excluded results. we claim, of end results most insurance is the proceeds non-GAAP collected already include claim as $XX million quarter, million by At of $XX GAAP third had end anticipate in the $XX part our quarter and this year. collecting pretax from which
of an shares the We for repurchased stock of $XXX available repurchases X Regarding the price during total at had approximately authorized share future per quarter third the million. common of repurchases, stock $XXX and share market in open we the a $XX.XX million end million of for at average quarter.
to expect the repurchase to fourth continue We in shares quarter.
cash million year. more operating Turning million cash $XX good flow third to of operating than was our for flow cash of last flow year. compares Year-to-date, last $XXX cash quarter, which flow. million million, $XXX had $XXX which with the We operating is
are unreasonable Turning to our able with estimate plan not provide costs At restructuring guidance. XXXX to updated financial without time, and associated this restructuring new XXXX. of we the effort for
to this include and Although primarily GAAP Therefore, pay are expect we providing we severance facility-related not guidance. costs.
current impact end future that is as as that include currency rates Our for well exchange and are repurchases. operations continuing current Guidance the of does current market closed also consistent not or remain levels future guidance foreign and consistent have XXXX assumes share potential that markets acquisitions acquisitions with generally with conditions.
XXXX growth is be of Our X% to to X% XXXX expected compared growth. total over prior to guidance sales to X% now X%
million. grow expect adjusted non-GAAP results of effective to XX%.
Consistent a of guidance, $XXX third EBITDA Henry of EPS compared This For low increasing range XXXX, Inc. in in we are non-GAAP the better-than-expected the $X.XX reflects diluted quarter. of X% EPS rate result compared in versus of with to tax as continue to $X.XX, guidance with an estimated to of non-GAAP reflects growth of X% with guidance to to Schein, to XXXX diluted and prior XXXX we EBITDA percentages XXXX the $X.XX double-digit attributable prior be adjusted our $X.XX $X.XX
on EBITDA a diluted because faster interest and have expense, effective We February. made my guidance plan.
I remarks plan on some coming comments strategic XXXX to call execute earnings conclude our QX on to with higher non-GAAP EPS of grow we the expect higher rate to result strategic depreciation this tax than our issue higher of a as XXXX. investments as will adjusted usual We
dental continued new and medical of expect have we recent heard recovery. you and in focused markets, by continue today, to grow year. our expect the And execution supported than product cyber improvement modest the next to launches we faster investments, and As markets some
should resulting in our restructuring from platform investments e-commerce from headwinds additional our target higher on are and this expense goal, to help global depreciation offset We technology. and achieve
to expect We the accelerate fully launched turn call back growth to e-commerce States.
With this in the once I'll now platform United that, Stanley.
